Maksimovic, Igor https://orcid.org/0000-0002-4379-6884
Finkin-Groner, Efrat https://orcid.org/0000-0002-1458-7098
Fukase, Yoshiyuki https://orcid.org/0000-0001-8088-2522
Zheng, Qingfei https://orcid.org/0000-0002-8397-3507
Sun, Shan https://orcid.org/0000-0001-8838-3226
Michino, Mayako https://orcid.org/0000-0002-5469-025X
Huggins, David J. https://orcid.org/0000-0003-1579-2496
Myers, Robert W. https://orcid.org/0000-0003-2599-1050
David, Yael https://orcid.org/0000-0003-1696-0025
Funding for this research was provided by:
National Institutes of Health (CCSG core grant P30 CA008748, MSK SPORE P50 CA192937, R21 DA044767, R35 GM13836)
Parker Institute for Cancer Immunotherapy
Pershing Square Foundation
Takeda Pharmaceutical Company
Memorial Sloan-Kettering Cancer Center
Rockefeller University
Weill Cornell Medical College
Robertson Foundation
RELATED DATA
IDENTIFIERS
PEER REVIEW METHOD
: Single-blind
PUBLICATION HISTORY
: Received 24 February 2021; Accepted 3 May 2021; Advance Article published 2 June 2021; Version of Record published 21 July 2021